Total Payments
$43,663
2024 Payments
$12,801
Companies
33
Transactions
371
Medicare Patients
18,042
Medicare Billing
$1.5M
Payment Breakdown by Category
Research$29,985 (68.7%)
Food & Beverage$11,283 (25.8%)
Travel$1,436 (3.3%)
Consulting$918.75 (2.1%)
Education$39.95 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $29,985 | 13 | 68.7% |
| Food and Beverage | $11,283 | 349 | 25.8% |
| Travel and Lodging | $1,436 | 7 | 3.3% |
| Consulting Fee | $918.75 | 1 | 2.1% |
| Education | $39.95 | 1 | 0.1% |
Payments by Type
Research
$29,985
13 transactions
General
$13,678
358 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Glaukos Corporation | $32,363 | 48 | $0 (2024) |
| Alcon Vision LLC | $2,539 | 84 | $0 (2024) |
| BIOTISSUE HOLDINGS INC. | $1,567 | 33 | $0 (2024) |
| Alcon Laboratories Inc | $1,536 | 22 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $853.13 | 38 | $0 (2023) |
| ABBVIE INC. | $719.08 | 25 | $0 (2024) |
| Amgen Inc. | $581.41 | 7 | $0 (2024) |
| Sight Sciences, Inc. | $379.64 | 11 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $374.31 | 13 | $0 (2021) |
| Sun Pharmaceutical Industries Inc. | $309.78 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,801 | 69 | Glaukos Corporation ($10,982) |
| 2023 | $3,258 | 50 | Glaukos Corporation ($1,381) |
| 2022 | $21,479 | 80 | GLAUKOS CORPORATION ($19,365) |
| 2021 | $1,216 | 37 | Alcon Vision LLC ($360.91) |
| 2020 | $534.49 | 21 | Glaukos Corporation ($201.28) |
| 2019 | $1,384 | 49 | Alcon Vision LLC ($682.24) |
| 2018 | $1,970 | 34 | Alcon Laboratories Inc ($1,167) |
| 2017 | $1,020 | 31 | Alcon Laboratories Inc ($368.80) |
All Payment Transactions
371 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $1.80 | General |
| 12/19/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $21.81 | General |
| 12/05/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: OPTOMETRY | ||||||
| 11/25/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $23.79 | General |
| 11/21/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $21.81 | General |
| 11/21/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $124.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $99.84 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/11/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | Cash or cash equivalent | $2.11 | General |
| 11/07/2024 | Alcon Vision LLC | AcrySof IQ PanOptix UV IOL (Device), AcrySof IQ VIVITY | Food and Beverage | In-kind items and services | $135.82 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $77.03 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $46.64 | General |
| Category: Glaucoma | ||||||
| 10/31/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $23.79 | General |
| 10/24/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Ophthalmology | ||||||
| 10/21/2024 | Glaukos Corporation | iDose (Device) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: Glaucoma | ||||||
| 10/19/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $39.53 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: EYE CARE | ||||||
| 10/05/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $2.11 | General |
| 10/03/2024 | Glaukos Corporation | Radius (Device) | Food and Beverage | Cash or cash equivalent | $8.37 | General |
| Category: Glaucoma | ||||||
| 10/02/2024 | Glaukos Corporation | GS-M-IS_iStent inject Trabecular Micro-Bypass System Model G2-M-IS (Device) | — | Cash or cash equivalent | $225.00 | Research |
| Study: iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study • Category: Glaucoma | ||||||
| 09/26/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 09/12/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $106.93 | General |
| Category: Dry eyes | ||||||
| 09/05/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $31.58 | General |
| Category: EYE CARE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| iStent Inject Trabecular Micro-Bypass System New Enrollment Post-Approval Study | Glaukos Corporation | $9,610 | 6 |
| Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% | Glaukos Corporation | $1,010 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,742 | 4,189 | $1.4M | $323,801 |
| 2022 | 20 | 4,323 | 4,817 | $1.5M | $348,254 |
| 2021 | 17 | 5,044 | 5,740 | $1.9M | $426,107 |
| 2020 | 18 | 4,933 | 5,645 | $1.9M | $440,166 |
Total Patients
18,042
Total Services
20,391
Medicare Billing
$1.5M
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 113 | 180 | $540,000 | $68,453 | 12.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 686 | 694 | $138,800 | $61,958 | 44.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 588 | 780 | $117,000 | $50,433 | 43.1% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 25 | 33 | $105,600 | $18,141 | 17.2% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 46 | 61 | $51,850 | $15,788 | 30.4% |
| 65820 | Incision to improve eye fluid flow | Facility | 2023 | 17 | 24 | $48,000 | $15,698 | 32.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 313 | 327 | $57,225 | $15,233 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 154 | $20,020 | $14,968 | 74.8% |
| 92250 | Photography of the retina | Office | 2023 | 464 | 465 | $55,800 | $12,496 | 22.4% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 96 | 96 | $24,000 | $9,470 | 39.5% |
| 92133 | Imaging of optic nerve | Office | 2023 | 341 | 343 | $85,750 | $8,731 | 10.2% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 381 | 386 | $30,880 | $7,817 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $13,545 | $7,041 | 52.0% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 137 | 220 | $35,860 | $6,763 | 18.9% |
| 92134 | Imaging of retina | Office | 2023 | 136 | 161 | $40,250 | $4,935 | 12.3% |
| 92286 | Imaging of front third of eye using a special microscope | Office | 2023 | 105 | 106 | $47,700 | $3,031 | 6.4% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 14 | 18 | $6,600 | $2,232 | 33.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 78 | 78 | $11,700 | $612.21 | 5.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 886 | 897 | $179,400 | $77,729 | 43.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 721 | 1,027 | $154,200 | $63,927 | 41.5% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 108 | 152 | $456,000 | $59,836 | 13.1% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 401 | 412 | $72,100 | $19,105 | 26.5% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 182 | 182 | $45,500 | $18,266 | 40.1% |
| 92250 | Photography of the retina | Office | 2022 | 544 | 546 | $65,520 | $15,094 | 23.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 41 | 56 | $47,600 | $14,553 | 30.6% |
About Dr. Andy Lee, MD
Dr. Andy Lee, MD is a Ophthalmology healthcare provider based in Duncanville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285746578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andy Lee, MD has received a total of $43,663 in payments from pharmaceutical and medical device companies, with $12,801 received in 2024. These payments were reported across 371 transactions from 33 companies. The most common payment nature is "" ($29,985).
As a Medicare-enrolled provider, Lee has provided services to 18,042 Medicare beneficiaries, totaling 20,391 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Duncanville, TX
- Active Since 08/31/2006
- Last Updated 12/03/2008
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1285746578
Products in Payments
- GS-M-IS_iStent inject Trabecular Micro-Bypass System Model G2-M-IS (Device) $9,610
- G2-TR_iDoseTR (Device) $1,010
- iDose TR (Drug) $918.75
- LenSx (Device) $610.26
- ARGOS (Device) $574.27
- XIIDRA (Drug) $567.17
- PROKERA (Device) $487.45
- TEPEZZA (Biological) $450.07
- VYZULTA (Drug) $365.44
- Clareon (Device) $362.60
- ENTRESTO (Drug) $332.17
- OMNI(R) SURGICAL SYSTEM (US) (Device) $290.26
- Cequa (Drug) $256.47
- iStent inject Trabecular Micro-Bypass System (Device) $250.34
- TEPEZZA (Drug) $241.76
- LUMIGAN (Drug) $239.26
- DURYSTA (Drug) $231.42
- AcrySof IQ PanOptix (Device) $229.52
- ACTIVEFOCUS (Device) $225.39
- VUITY (Drug) $215.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.